To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. Our first job is to listen to and observe what our customers need, and meet those needs with quality products and services. While we are not currently experiencing delays due to this pandemic, we expect that we could see them as the situation evolves. If you experience any issues, please contact ATCC Customer Service at sales@atcc.org. For Technical questions please contact tech@atcc.org. Thank you for your understanding, patience and flexibility as ATCC does everything it can to help reduce the impact of the coronavirus pandemic to our valued customers.
X

Differentiated iPSCs

Toxicology and cancer researchers struggle to find cell models with high physiological relevance and the ability to be run in an assay over and over again without introducing variability. To fulfill this need, ATCC scientists have differentiated induced pluripotent stem cells (iPSCs) into widely used cells such as mesenchymal stem cells, CD34+ cells, and monocytes. They may be used to build physiologically relevant cell-based assays for drug development in fields such as regenerative medicine, hematology, oncology, and toxicology.



  • Can be terminally differentiated into your desired cell type
  • Ideal for cell-based assay development
  • Provides a virtually unlimited source of cells
  • Eliminates donor variability 
  • Offers high interexperimental reproducibility
  • Predictive of the in vivo situation

Toxicology Tools

Toxicology Testing

It is critical that the standards and model organisms used in toxicological testing are reliable and authenticated. ATCC has the credible models needed to perform standardized, reliable, and reproducible toxicology studies.

Media and Sera

Media
Sera

While it's recommended to use application specific formulations to grow your iPSCs, ATCC can provide high quality basics such as RPMI, EMEM, and FBS to ensure the success of your experiments.

Custom Solutions

Contact us


Need an affordable solution to deriving primary cells from iPSCs? Is CRISPR/Cas9 gene editing, next-generation model development, nucleic acid extractions, or cell provisioning & authentication in your workflow? ATCC can help with customized services and solutions to meet your specific assay development needs.